Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: IRIDEX Corporation

Market Cap 19.67M 17.07M 15.73M 14.74M 27.55M 1.88B 28.12M 188M 72.67M 908M 73.84M 72.25M 3.16B P/E Ratio 2026 *
-22.6x
P/E Ratio 2027 * 56.5x
Enterprise Value 19.67M 17.07M 15.73M 14.74M 27.55M 1.88B 28.12M 188M 72.67M 908M 73.84M 72.25M 3.16B EV / Sales 2026 *
0.37x
EV / Sales 2027 * 0.35x
Free-Float
68.77%
Yield 2026 *
-
Yield 2027 * -
1 day-0.44%
1 week-2.09%
Current month+7.24%
1 month+7.24%
3 months-15.97%
6 months+16.02%
Current year-1.23%
1 week 1.09
Extreme 1.09
1.18
1 month 0.98
Extreme 0.98
1.2
Current year 0.95
Extreme 0.9496
1.65
1 year 0.87
Extreme 0.8688
1.65
3 years 0.78
Extreme 0.782
3.65
5 years 0.78
Extreme 0.782
9.46
10 years 0.78
Extreme 0.782
16.64
Manager TitleAgeSince
Chief Executive Officer 54 01/10/2024
Director of Finance/CFO 68 18/12/2018
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 24/06/2020
Director/Board Member 54 01/09/2018
Director/Board Member 66 17/03/2022
Date Insider Type Main position Quantity % Market Cap.
06-08Buy

Chief Financial Officer

2,400 0.0138%
06-05Buy

Chief Financial Officer

2,521 0.0145%
06-03Buy

Chief Financial Officer

2,400 0.0138%
Change 5-day change 1-year change 3-year change Capi.($)
-0.35%-2.09%+21.06%-40.42% 19.67M
-1.26%-1.37%+14.52%-9.21% 179B
+0.42%-0.97%-20.60%+32.24% 146B
-1.37%-2.94%-11.51%-23.90% 130B
-0.90%-1.90%-51.79%-6.41% 71.85B
+0.35%-1.33%+14.34%+0.84% 49.51B
-1.99%-0.72%-26.09%-34.75% 45.25B
-1.76%-6.48%+8.09%+9.16% 37.17B
-0.66%-4.26%+4.15%+40.28% 35.66B
+0.90%+0.88%-12.30%-17.76% 29B
Average -0.58%+0.91%-6.01%-4.99% 72.35B
Weighted average by Cap. -0.71%+1.56%-8.29%-1.08%

Financials

2026 *2027 *
Net sales 53M 45.99M 42.4M 39.73M 74.22M 5.07B 75.77M 506M 196M 2.45B 199M 195M 8.51B 56.77M 49.26M 45.41M 42.55M 79.5M 5.44B 81.15M 542M 210M 2.62B 213M 209M 9.11B
Net income -795K -690K -636K -596K -1.11M -76.12M -1.14M -7.59M -2.94M -36.69M -2.98M -2.92M -128M 361K 313K 289K 271K 506K 34.57M 516K 3.44M 1.33M 16.66M 1.36M 1.33M 57.93M
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
11/06/26 1.126 $ -0.35% 22,371
10/06/26 1.130 $ +0.89% 15,611
09/06/26 1.120 $ +0.90% 87,644
08/06/26 1.110 $ +1.83% 35,560
05/06/26 1.090 $ -5.22% 137,411
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.130USD
Average target price
2.750USD
Spread / Average Target
+143.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!